Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Change in Account Payables (2024 - 2025)

Historic Change in Account Payables for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to $1.1 million.

  • Beta Bionics' Change in Account Payables rose 93773.58% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $1.5 million for FY2024, which is 11159.22% up from last year.
  • Beta Bionics' Change in Account Payables amounted to $1.1 million in Q3 2025, which was up 93773.58% from $568000.0 recorded in Q2 2025.
  • Over the past 5 years, Beta Bionics' Change in Account Payables peaked at $1.1 million during Q3 2025, and registered a low of -$97000.0 during Q1 2025.